Phreesia, Inc.

PHR Healthcare Health Information Services

Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025. In the quarter to July 2026, revenue grew 10.4%, EPS grew 200.0%, free cash flow grew 43.5% and total debt rose 3,191.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

10.94 0.10 −0.91%
Market cap
$685.3M
P/E
64.4×
Fwd P/E
23.5×
Dividend yield
—
F-score
5/9
Altman Z
0.65
Beneish M
−2.15
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
Piotroski F-Score

+8 more TTM periods

7 5 4 4
ROE
(1.87%) 0.77% 2.86% 3.12%
ROA
(1.35%) 0.44% 1.72% 1.98%
ROIC
(2.49%) (0.94%) 0.46% 1.74%
Return on Tangible Assets
(3.30%) 1.97% 6.77% 8.18%
Average Days of Receivables
69.55 117.44 105.54 96.52
Free Cash Flow per Share
0.58 0.91 1.04 1.09
Free Cash Flow
35.09 54.42 63.33 67.52
Capital Expenditures
(26.32) (24.40) (24.55) (23.86)
Other line items
Cash ROIC
8.16% 9.28% 10.38% 11.34%
Accounts Receivable Turnover
5.80 4.21 4.54 4.81
Accounts Payable Turnover
13.34 18.03 21.12 17.58
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
15.41 27.18 27.23 27.08
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.35 (1.26) (9.85) 2.78
Research and Development Expense of Revenue
25.95% 25.28% 23.81% 22.90%
Selling, General and Administrative Expense of Revenue
37.95% 37.48% 36.37% 34.84%
Share Based Compensation of Revenue
14.37% 14.04% 12.87% 11.70%
Interest Coverage
— (0.83) 0.37 1.19
Operating CF/Net income
(11.42) 34.18 9.57 8.75
Depreciation/Fixed assets
1.39 1.72 1.87 2.26
Capex/Depreciation
(0.89) (0.70) (0.64) (0.58)
Revenue per Share
7.72 8.05 8.13 8.21
Operating CF per Share
1.02 1.32 1.44 1.48
Capex per Share
(0.44) (0.41) (0.40) (0.39)
Capex to Sales
0.06 0.05 0.05 0.05

Fold the line items

Columns are period end dates